Dapiprazole Hydrochloride

盐酸达哌拉唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDapiprazole Hydrochloride
Drug Alias Namedapiprazolum达哌唑dapiprazolGlamidoloRemydrial +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonistsAdrenergic receptor alpha-1 agonists
TargetsAdrenergic receptors alpha-1Adrenergic receptors alpha-2
Therapy Area/IndicationsMydriasis
Global Approved IndicationsMydriasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/12/31
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesFera Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFera Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsMydriasis

Other Information

ATC CodeS01EX02
Related LinksWikipediaDrugBankKEGG